Bone Biologics Co. (OTC:BBLG – Get Free Report)’s stock price traded up 1.9% on Thursday . The company traded as high as $0.87 and last traded at $0.86. 296,298 shares traded hands during trading, an increase of 60% from the average session volume of 185,384 shares. The stock had previously closed at $0.84.
Bone Biologics Price Performance
The company’s fifty day simple moving average is $0.94 and its 200-day simple moving average is $1.22. The firm has a market capitalization of $2.36 million, a PE ratio of -0.01 and a beta of 0.53.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Featured Stories
- Five stocks we like better than Bone Biologics
- Why Invest in High-Yield Dividend Stocks?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- The How And Why of Investing in Oil Stocks
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- How to Start Investing in Real Estate
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
